Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression

Hung T.-C.Chen G.-J.Cheng S.-H.Chen J.-H.Wei J.-L.Cheng C.-Y.CHIEN-CHING HUNG2021-12-012021-12-0120191684-1182https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070541055&doi=10.1016%2fj.jmii.2019.07.002&partnerID=40&md5=deba57f2494c57ec0480fcac90c9c7a9https://scholars.lib.ntu.edu.tw/handle/123456789/588729[SDGs]SDG3Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppressionjournal article10.1016/j.jmii.2019.07.002314220592-s2.0-85070541055